D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$555M |
| 2 |
Marathon Petroleum
MPC
|
+$538M |
| 3 |
Ford
F
|
+$529M |
| 4 |
Walmart
WMT
|
+$508M |
| 5 |
Apple
AAPL
|
+$499M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Merck
MRK
|
+$498M |
| 3 |
Meta Platforms (Facebook)
META
|
+$425M |
| 4 |
McDonald's
MCD
|
+$369M |
| 5 |
Wells Fargo
WFC
|
+$362M |
Sector Composition
| 1 | Technology | 20.88% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTOC
2151
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
| $1.39M | ﹤0.01% |
+143,181
| New | +$1.39M |
|
2152
SoFi Technologies
SOFI
$31.8B
| $1.39M | ﹤0.01% |
+72,327
| New | +$1.39M |
|
|
HCII
2153
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $1.39M | ﹤0.01% |
+142,874
| New | +$1.39M |
|
2154
Akamai
AKAM
$11B
| $1.37M | ﹤0.01% |
+11,736
| New | +$1.37M |
|
|
VLDR
2155
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $1.37M | ﹤0.01% |
+128,451
| New | +$1.37M |
|
2156
Palladyne AI
PDYN
$309M
| $1.36M | ﹤0.01% |
+22,780
| New | +$1.36M |
|
2157
First Financial Bancorp
FFBC
$2.46B
| $1.36M | ﹤0.01% |
57,555
-125,928
| -69% | -$2.98M |
|
2158
CRH
CRH
$76.1B
| $1.35M | ﹤0.01% |
26,638
-262,103
| -91% | -$13.3M |
|
|
DHHCU
2159
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
| $1.35M | ﹤0.01% |
135,510
+26,141
| +24% | +$261K |
|
|
DOOR
2160
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.35M | ﹤0.01% |
12,068
-6,659
| -36% | -$744K |
|
|
ARBG
2161
DELISTED
Aequi Acquisition Corp. Class A Common Stock
ARBG
| $1.35M | ﹤0.01% |
+138,388
| New | +$1.35M |
|
|
CMRX
2162
DELISTED
Chimerix, Inc.
CMRX
| $1.34M | ﹤0.01% |
167,941
-18,260
| -10% | -$146K |
|
2163
New Mountain Finance
NMFC
$1.11B
| $1.34M | ﹤0.01% |
101,886
+90,191
| +771% | +$1.19M |
|
|
GLHAU
2164
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
| $1.34M | ﹤0.01% |
+132,372
| New | +$1.34M |
|
2165
Cal-Maine
CALM
$5.37B
| $1.34M | ﹤0.01% |
36,888
-84,094
| -70% | -$3.05M |
|
|
ESTE
2166
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.34M | ﹤0.01% |
120,721
-48,548
| -29% | -$537K |
|
2167
Northfield Bancorp
NFBK
$492M
| $1.34M | ﹤0.01% |
81,432
-30,085
| -27% | -$493K |
|
|
BBT
2168
Beacon Financial Corporation
BBT
$2.17B
| $1.33M | ﹤0.01% |
48,458
-37,789
| -44% | -$1.04M |
|
|
ANSS
2169
DELISTED
Ansys
ANSS
| $1.32M | ﹤0.01% |
3,815
+3,155
| +478% | +$1.09M |
|
2170
CureVac
CVAC
$1.2B
| $1.32M | ﹤0.01% |
+18,009
| New | +$1.32M |
|
|
HMTV
2171
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $1.32M | ﹤0.01% |
111,989
-15,092
| -12% | -$178K |
|
2172
Y-mAbs Therapeutics
YMAB
$390M
| $1.32M | ﹤0.01% |
39,083
-41,382
| -51% | -$1.4M |
|
2173
Vera Bradley
VRA
$61.5M
| $1.32M | ﹤0.01% |
106,514
-185,387
| -64% | -$2.3M |
|
2174
CDW
CDW
$21.5B
| $1.31M | ﹤0.01% |
7,523
-203,293
| -96% | -$35.5M |
|
2175
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.31M | ﹤0.01% |
94,862
-174,771
| -65% | -$2.42M |
|